How does Alocuro PRO-PRP compare with other manual PRP kits?
Superior PRP efficiency
Alocuro’s PRO-PRP device and preparation protocol has demonstrated outstanding performance in extracting, separating, and collecting PRP from patient’s blood with documented platelet concentration of up to a multiple of 12.8x platelet concentration above physiological baseline level, and a platelet recovery efficiency of 88%. This efficiency is significantly superior to other manual preparation PRP kits currently available in Australia.
Leukocyte poor PRP is achievable with Alocuro’s PRO-PRP
If a leukocyte poor PRP is required then the platelet concentration can be reduced to within the range of 4 – 6 x baseline concentration.
Intact, non-activated Platelets for optimal release of growth factors upon injection
Apart from standard anti-coagulation of ACD-A or CPDA, PRO-PRP does not require the use of any foreign material e.g. activation material or thixotropic gel separation to separate the cellular components. This ensures that the patient is receiving a pure, unaltered by chemicals, autologous blood product, which minimises the risk of reaction to and complications from the PRP injection. In-situ activation of platelets (injected platelets being exposed to collagen and endothelium) is beneficial for stimulating a continuous healing response due to slower release of growth factors.
Parameters that need to be included for comparative optimisation of PRP preparation protocols include:
- the absolute number and concentration of platelets over baseline, should be ideally 3X
- the absolute number and concentration of leukocytes / WBC below baseline, should be physiological baseline or less
- the absolute number and concentration of RBC below physiological baseline- should ideally be nil
- the choice between exogenous pre-activation of platelets or not,
- the number of injections or applications (topical),
- and the delay between injections or applications ( topical)
Need a PRP protocol that:
- standardises the preparation of PRP
- emphasis on overall preservation of platelets’ physiological properties until time of injection
- reproducible in any clinical setting,
- cost-effective delivery of growth factors,